Pancreatic Cancer Research

ResearcherMoffitt Cancer CenterActive in the last 2 years

Shari Pilon-Thomas

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7785-3034; OpenAlex author ID A5006278901; NIH RePORTER profile ID 8791968. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
1
Labs led
1
Collaborators
8
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper, 1 grant

Papers 3

  1. L-DOS47 Elevates Pancreatic Cancer Tumor pH and Enhances Response to Immunotherapy. Co-author DOI 10.3390/biomedicines12020461↗
  2. Murine pancreatic adenocarcinoma reduces Ikaros expression and disrupts T cell homeostasis. Co-author DOI 10.1371/journal.pone.0115546↗
  3. Murine pancreatic adenocarcinoma dampens SHIP-1 expression and alters MDSC homeostasis and function. Co-author DOI 10.1371/journal.pone.0027729↗

Grants 1

  1. Imaging Acidosis and Immune Therapy in PDAC R01CA239219↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Robert J. Gillies · 1 shared paper, 1 shared grant, 2024 · strength 0.89
  2. Arig A Ibrahim Hashim · 1 shared grant, 2024 · strength 0.72
  3. Bruna Victorasso Jardim‐Perassi · 1 shared paper, 2024 · strength 0.16
  4. Barbara Ann Centeno · 1 shared paper, 2024 · strength 0.16
  5. Tomar Ghansah · 2 shared papers, 2011–2015 · strength 0.08
  6. Nadine Nelson · 2 shared papers, 2011–2015 · strength 0.08
  7. Kazim M. Husain · 1 shared paper, 2015 · strength 0.05
  8. Mokenge Peter Malafa · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.